Effectiveness of minocycline in acute white matter injury after intracerebral hemorrhage

J Neurosurg. 2017 Jun;126(6):1855-1862. doi: 10.3171/2016.5.JNS152670. Epub 2016 Aug 5.

Abstract

OBJECTIVE Intracerebral hemorrhage (ICH) is a fatal disease with high morbidity and mortality, which may be followed by white matter injury (WMI) due to the local oxidizing reaction induced by iron (Fe). In this study, the authors examined the effect of the tetracycline antibiotic minocycline on Fe-induced WMI and c-Jun N-terminal kinase (JNK) activation in rats. METHODS Thirty-six male Sprague-Dawley rats underwent an intracaudate injection of saline, Fe, or Fe + minocycline. Another 36 rats had an intracaudate injection of autologous blood and were treated with minocycline or vehicle (saline). Biomarkers of both WMI and JNK activation were examined. RESULTS In the Fe-injection group, minocycline suppressed WMI labeled by β-amyloid precursor protein (β-APP) and degraded myelin basic protein (dMBP)/MBP ratio. Protein levels of phosphorylated-JNK were increased after Fe injection, and could be suppressed by minocycline treatment. In the autologous blood-injection group, β-APP and dMBP/MBP levels increased in the ipsilateral site compared with the contralateral site, which could be suppressed by 7 days of minocycline intervention. CONCLUSIONS Iron plays a critical role in WMI after ICH, which can be suppressed by minocycline through reducing the damage induced by Fe.

Keywords: APP = amyloid precursor protein; Fe; GAPDH = glyceraldehyde 3-phosphate dehydrogenase; ICH = intracerebral hemorrhage; JNK = c-Jun N-terminal kinase; MBP = myelin basic protein; WMI = white matter injury; c-Jun N-terminal kinase; dMBP = degraded MBP; intracerebral hemorrhage; iron; minocycline; vascular disorders; white matter injury.

MeSH terms

  • Amyloid beta-Protein Precursor / metabolism
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Cerebral Hemorrhage / complications*
  • Cerebral Hemorrhage / metabolism
  • Cerebral Hemorrhage / pathology
  • Disease Models, Animal
  • Leukoencephalopathies / drug therapy*
  • Leukoencephalopathies / etiology
  • Leukoencephalopathies / metabolism
  • Leukoencephalopathies / pathology
  • Male
  • Minocycline / pharmacology
  • Minocycline / therapeutic use*
  • Myelin Basic Protein / metabolism
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • White Matter / drug effects*
  • White Matter / metabolism
  • White Matter / pathology

Substances

  • Amyloid beta-Protein Precursor
  • Anti-Bacterial Agents
  • Myelin Basic Protein
  • Minocycline